Accelerating antiviral drug discovery: lessons from COVID-19

During the coronavirus disease 2019 (COVID-19) pandemic, a wave of rapid and collaborative drug discovery efforts took place in academia and industry, culminating in several therapeutics being discovered, approved and deployed in a 2-year time frame. This article summarizes the collective experience...

Descripción completa

Detalles Bibliográficos
Autores principales: von Delft, Annette, Hall, Matthew D., Kwong, Ann D., Purcell, Lisa A., Saikatendu, Kumar Singh, Schmitz, Uli, Tallarico, John A., Lee, Alpha A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176316/
https://www.ncbi.nlm.nih.gov/pubmed/37173515
http://dx.doi.org/10.1038/s41573-023-00692-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176316/
https://www.ncbi.nlm.nih.gov/pubmed/37173515
http://dx.doi.org/10.1038/s41573-023-00692-8

Ejemplares similares